Intractable epistaxis associated with topiramate administration

Annals of Pharmacotherapy

Volumn 40, Issue 7-8, 2006, Pages 1462-1465

  Page II, Robert L ^a   Bainbridge, Jacquelyn L ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Epistaxis; Topiramate

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CLOPIDOGREL; GABAPENTIN; MORPHINE; PACLITAXEL; PREDNISONE; SODIUM CHLORIDE; TOPIRAMATE; VOLTAGE GATED CALCIUM CHANNEL;

ADULT; ANGINA PECTORIS; ARTICLE; BLEEDING; BLEEDING TIME; CARDIOVASCULAR DISEASE; CASE REPORT; DIAPHORESIS; DRUG DOSE REGIMEN; DRUG ELUTING STENT; DRUG INDICATION; DRUG MECHANISM; DYSPNEA; EMERGENCY WARD; EPISTAXIS; ERYTHROCYTE CONCENTRATE; FEMALE; HEMATOLOGICAL PARAMETERS; HOSPITAL ADMISSION; HUMAN; INTRACTABLE EPISTAXIS; LEG DISEASE; MIGRAINE; NAUSEA; NEUROMODULATION; NEUROPATHIC PAIN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SEDATION; SIDE EFFECT; THORAX PAIN; TONIC CLONIC SEIZURE; UNSTABLE ANGINA PECTORIS; VOMITING;

DIABETIC NEUROPATHIES; EPISTAXIS; FEMALE; FRUCTOSE; HUMANS; MIDDLE AGED; PAIN;

EID: 33747029911     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H078     Document Type: Article

References (27)

1. Package insert. Topamax (topiramate). Titusville, NJ: Ortho-McNeil Neurologies, June 2005.
2. Chong MS, Libretto SE. The rationale and use of topiramate for treating neuropathic pain. Clin J Pain 2003;19:59-68.
3. Johnson BA. Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function. CNS Drugs 2005;19:873-96.
4. Brandes JL. Practical use of topiramate for migraine prevention. Headache 2005;45(suppl 1):S66-73.
5. Scaramuzzi N, Walsh RM, Brennan P, Walsh M. Treatment of intractable epistaxis using arterial embolization. Clin Otolaryngol Allied Sci 2001; 26:307-9.
6. Sparacino LL. Epistaxis management: what's new and what's noteworthy. Lippincotts Prim Care Pract 2000;4:498-507.
7. White HS. Molecular pharmacology of topiramate: managing seizures and preventing migraine. Headache 2005;45(suppl 1):S48-56.
8. Russo E, Constanti A, Ferreri G, Citraro R, De Sarro G. Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy. Neuropharmacology 2004;46:865-78.
9. Pahor M, Guralnik JM, Furberg CD, Carbonin P, Havlik R. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet 1996;347:1061-5.
10. Dale J, Landmark KH, Myhre E. The effects of nifedipine, a calcium antagonist, on platelet function. Am Heart J 1983;105:103-5.
11. Saunders FW, Shedden P. Diltiazem: possible hematologic complications. Surg Neurol 1986;25:82-4.
12. Kaplan RC, Heckbert SR, Koepsell TD, Rosendaal FR, Psaty BM. Use of calcium channel blockers and risk of hospitalized gastrointestinal tract bleeding. Arch Intern Med 2000;160:1849-55.
13. Smith A, McPherson J, Taylor M, Mason A, Carney S, Gillies A. Prohaemorrhagic effects of calcium antagonists: a comparison of isradipine and atenolol on ex vivo platelet function in hypertensive subjects. J Hum Hypertens 1997;11:783-8.
14. Kario K, Imiya M, Ohta Y, Shimada K. Gastrointestinal bleeding induced by amlodipine. J Hum Hypertens 1995;9:206-7.
15. Tay HL, Evans JM, McMahon AD, MacDonald TM. Aspirin, nonsteroidal anti-inflammatory drugs, and epistaxis. A regional record linkage case control study. Ann Otol Rhinol Laryngol 1998;107:671-4.
16. Black HR, Elliott WJ, Grandits G, et al. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA 2003;289:2073-82.
17. Ring ME, Corrigan JJ, Fenster PE. Effects of oral diltiazem on platelet function: alone and in combination with "low dose" aspirin. Thromb Res 1986;44:391-400.
18. Altman R, Scazziota A, Dujovne C. Diltiazem potentiates the inhibitory effect of aspirin on platelet aggregation. Clin Pharmacol Ther 1988;44:320-5.
19. Cremer KF, Pieper JA, Joyal M, Mehta J. Effects of diltiazem, dipyiridamole, and their combination on hemostasis. Clin Pharmacol Ther 1984;36:641-4.
20. Kristensen SD, Schmidt EB, Dyerberg J. Verapamil does not alter platelet function in patients with recent myocardial infarction. Thromb Res 1983; 32:437-42.
21. Lanas A, Serrano P, Bajador E, Fuentes J, Sainz R. Risk of upper gastrointestinal bleeding associated with non-aspirin cardiovascular drugs, analgesics and nonsteroidal anti-inflammatory drugs. Eur J Gastroenterol Hepatol 2003;15:173-8.
22. Pales J, Palacios-Araus L, Lopez A, Gual A. Effects of dihydropyridines and inorganic calcium blockers on aggregation and on intracellular free calcium in platelets. Biochim Biophys Acta 1991;1064:169-74.
23. Abernethy DR, Schwartz JB. Calcium-antagonist drugs. N Engl J Med 1999;341:1447-57.
24. Vinik A. Clinical review, use of antiepileptic drugs in the treatment of chronic painful diabetic neuropathy. J Clin Endocrinol Metab 2005; 90:4936-45.
25. Bialer M, Doose DR, Murthy B, et al. Pharmacokinetic interactions of topiramate. Clin Pharmacokinet 2004;43:763-80.
26. Lubianca Neto JF, Fuchs FD, Facco SR, et al. Is epistaxis evidence of end-organ damage in patients with hypertension? Laryngoscope 1999; 109:1111-5.
27. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.